APDN to Report FQ2’23 Financial Results; Investor Conference Call/Webcast 5/11
STONY BROOK, N.Y. – May 3, 2023 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it will release financial results for the three months ended March 31, 2023 after the market close on Thursday, May 11, 2023. The Company [...]